Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 13:8:795016.
doi: 10.3389/fcvm.2021.795016. eCollection 2021.

Prognostic Value of the Three-Dimensional Right Ventricular Ejection Fraction in Patients With Asymptomatic Aortic Stenosis

Affiliations

Prognostic Value of the Three-Dimensional Right Ventricular Ejection Fraction in Patients With Asymptomatic Aortic Stenosis

Yosuke Nabeshima et al. Front Cardiovasc Med. .

Abstract

Background: The right ventricular (RV) function is an important prognostic marker of asymptomatic aortic stenosis (AS). However, previous publications have not addressed the additive value of conventional RV parameters over left heart parameters. Whether three-dimensional echocardiography (3DE)-derived RV ejection fraction (RVEF) has prognostic utility independent of 3DE derived left heart parameters is also unknown. We investigated the prognostic utility of 3DE RVEF in patients with asymptomatic AS. Methods: We retrospectively selected 392 asymptomatic AS patients. RVEF, left ventricular ejection fraction (LVEF) and left atrial volumes (LAVs) were measured using 3DE datasets. We determined the association of those parameters, as well as of aortic valve replacement (AVR), and Charlson's comorbidity index with cardiac events. We also analyzed whether RVEF has incremental value over two-dimensional echocardiography (2DE) RV parameters. Results: During a median follow-up of 27 months, 57 patients developed cardiac events, and 68 patients received AVR. Univariate Cox proportional hazard analysis revealed that RVEF was associated with cardiac events (p < 0.001). Multivariate analysis revealed that RVEF was significantly associated with cardiac events (p < 0.001) even after adjusting for AVR, Charlson's comorbidity index, LVEF, LAV, E/e', and indexed aortic valve area (iAVA). An incremental value of RVEF over left heart parameters was also demonstrated using a nested regression model. Classification and regression-tree analysis selected RVEF first with a cut-off value of 41%. RVEF had incremental value over iAVA, LVEF, and 2DE conventional RV parameters for its association with future outcomes. Conclusions: 3DE RVEF had significant prognostic value even after adjusting for comorbidities, left heart parameters, and conventional 2DE RV parameters in asymptomatic aortic stenosis.

Keywords: 3DE; CART analysis; RVEF; asymptomatic aortic stenosis; prognosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Representative 3D RV and LV analyses in a patient with asymptomatic AS who developed a cardiac event. A 74-year-old woman who developed heart failure three months after baseline echocardiography. AS was moderate and LVEF was preserved; however, RVEF was reduced. She also had hypertension, chronic kidney disease, and chronic obstructive pulmonary disease. 3D, three-dimensional; AS, aortic stenosis; ED, end-diastole; ES, end-systole; iAVA, indexed aortic valve area; LV, left ventricular; LVEF, left ventricular ejection fraction; PG, pressure gradient; RV, right ventricular; RVEF, right ventricular ejection fraction.
Figure 2
Figure 2
Receiver-operating characteristic curve analysis for prediction of cardiac events. Comparison of the area under the curve (AUC) of several parameters (black line) and with RVEF added (green line). LAVIn, minimum left atrial volume index; LVEF, left ventricular ejection fraction; PG, pressure gradient; RVEF, right ventricular ejection fraction.
Figure 3
Figure 3
Classification and regression-tree analysis for cardiac events. Blue boxes denote cut-offs, and red boxes describe event rates. 3D, three-dimensional; AVR, aortic valve replacement; LAVIn, minimum left atrial volume index; LVEF, left ventricular ejection fraction; PG, pressure gradient; RVEF, right ventricular ejection fraction.
Figure 4
Figure 4
Kaplan-Meier survival analysis for cardiac events based upon RVEF and LVEF. Kaplan-Meier analysis for cardiac events, according to group, as classified by lower limits of normal LVEF and RVEF. LVEF, left ventricular ejection fraction; RVEF, right ventricular ejection fraction.

References

    1. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. . Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. (2018) 137:e67–492. 10.1161/CIR.0000000000000558 - DOI - PubMed
    1. Goldsweig AM, Tak HJ, Chen LW, Aronow HD, Shah B, Kolte DS, et al. . The evolving management of aortic valve disease: 5-year trends in SAVR, TAVR, and medical therapy. Am J Cardiol. (2019) 124:763–71. 10.1016/j.amjcard.2019.05.044 - DOI - PMC - PubMed
    1. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, et al. . 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. (2017) 135:e1159–95. 10.1161/CIR.0000000000000503 - DOI - PubMed
    1. Pai RG, Kapoor N, Bansal RC, Varadarajan P. Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. Ann Thorac Surg. (2006) 82:2116–22. 10.1016/j.athoracsur.2006.07.043 - DOI - PubMed
    1. Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol. (1990) 15:1012–7. 10.1016/0735-1097(90)90234-G - DOI - PubMed